Evidence

The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer

February 1, 2010

PUBLICATION: Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub 2009 Feb 13. AUTHORS: Straver M.E., Glas A.M., Hannemann J., Wesseling J., van de Vijver M.J., Rutgers E.J., Vrancken Peeters M.J., van Tinteren H., Van’t Veer L.J., Rodenhuis S. SUMMARY: 144 (86%) were having a poor and 23 (14%) a good prognosis-signature. None of the good prognosis-signature patients…

Read more